A double-blind, placebo-controlled trial of topical I,25-dihydroxycholecalciferol in psoriasis.
In a double-blind trial of topical I,25-dihydroxycholecalciferol in 47 patients with psoriasis no benefit was shown compared with placebo.
Henderson
C A
CA
Department of Dermatology, York District Hospital, U.K.
Papworth-Smith
J
J
Cunliffe
W J
WJ
Highet
A S
AS
Shamy
H K
HK
Czarnetzki
B M
BM
D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D000368:Aged; D002117:Calcitriol / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*
D002117:Calcitriol